.avif)
Genentech Email Format
Biotechnology Research
・
10,001+ employees
・
South San Francisco, CA, USA
Genentech is a biotechnology research company that uses cutting-edge science to develop and deliver innovative medicines for difficult-to-treat conditions worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
last.first@gene.com
Company Overview
Industry
Biotechnology Research
Founded
1976
Headquarters
South San Francisco, CA, USA
Revenue
$5B-$10B
FUNDING Stage
Subsidiary
Website
Key Executives
Ashley Magargee (Chief Executive Officer), Matteo Pietra (Chief Financial Officer), Wafaa Mamilli (Executive Vice President and Chief Digital Technology Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Genentech?
Genentech uses the last.first format, so Jane Smith would be smith.jane@gene.com.
What therapeutic areas does Genentech focus its research and medicines on?
Genentech focuses on five therapeutic areas: oncology and hematology, neurology, immunology, ophthalmology, and cardiovascular, renal, and metabolism (CVRM). The company currently has more than 66 investigational medicines across these areas in clinical development.
How does Genentech's oncology pipeline compare to other biopharmaceutical companies?
Genentech has more than 20 immunotherapy molecules in development within its oncology and hematology pipeline, which it describes as one of the broadest and most diverse in the industry. The company has also earned 43 FDA Breakthrough Therapy Designations since 2013.
Who leads Genentech as CEO in 2026?
Ashley Magargee leads Genentech as Chief Executive Officer. She was appointed to the role effective January 1, 2024, and also serves on Genentech's Board of Directors. Genentech is a member of the Roche Group, headquartered in South San Francisco, California.
When was Genentech founded, and what research division does it operate within the Roche Group?
Genentech was founded in 1976 by Herbert Boyer and Robert Swanson and became part of the Roche Group in 2009. It operates as Genentech Research and Early Development (gRED), a distinct research unit within Roche focused on discovering and developing new medicines. You can use Clay to find and verify specific Genentech research contacts by department.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating